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Endotoxin (lipopolysaccharide, LPS) 1 is selectively mitogenic for a subpopula- 
tion of B lymphocytes, but is not directly mitogenic on peripheral or thymus T 
lymphocytes  (1-6).  On the other hand,  the adjuvant effects of LPS in vivo in 
enhancing antibody formation may involve T lymphocytes (7-11).  LPS effects on 
in vitro antibody production and B-cell mitogenesis (12) have also been associ- 
ated with T-cell action (13-15).  Forbes et al.  (16) and Ozato et al.  (17) reported 
that LPS stimulated the immunocompetent minor subpopulation of  thymus cells 
in synergy  with small  amounts of the T-mitogen concanavalin A  (Con A) or 
alloantigen. Similar effects have been reported using human peripheral T cells 
(18). Others (14, 19) have failed to find synergy of LPS responses in mixtures of 
spleen  or  lymph  node  and  thymus  cells.  This  paper  shows  that  the  major 
immunoincompetent subpopulation of mouse thymus contains cells which act in 
synergy with peripheral lymphoid B cells to regulate proliferative responses to 
LPS. 
Materials and Methods 
Animals.  Female C57BL/10, C57BL/10.A, C3Heb/Fej, CBA/H-T6J, or CBA/Caj C3H/Hej 6-20 
wk of age were obtained from The Jackson Laboratory, Bar Harbor, Maine. In experiments not 
reported here, it was found that the LPS high responder (C3Heb/Fej)  and low responder strains 
(C3H/Hej)  are  not  mutually  stimulatory in  MLC  at  a  level detectable  in  the  culture  system 
employed. 
Preparation of Cells.  Thymus, spleen, or lymph node  cells were obtained by pressing small 
tissue fragments through 60-mesh stainless steel screens and then serially drawing the suspension 
in RPMI-1640 (Grand Island Biological Company, Grand Island, N. Y.) through 19-, 23-, and 25- 
gauge needles. 
Bovine Serum Albumin (BSA) Gradient Separation.  BSA gradients were prepared according 
to methods described elsewhere (20) using BSA concentrations as follows: A-layer above 23%, B- 
layer above 27%, C-layer above 29%, and D-layer above 35%. Cells to be separated were layered on 
the upper layer, centrifuged at 13,000 rpm in a Beckman SW50.1 rotor for 30 min, washed with 
RPMI, and resuspended in complete culture medium (see below). 
* This work was supported in part by National Institutes of Health grants HD-00384, CA-15334, 
CA-09126, and CB-53933. This is Tumor Biology Unit publication no.  113. 
Abbreviations used in this paper:  BSA, bovine serum albumin; BSS, balanced salt solution; 
Con A, concanavalin A; [3H]TdR, tritiated thymidine; LAF, lymphocyte-activating factor; LN, 
lymph node; LPS, lipopolysaccharide; MLR, mixed lymphocyte reaction; PHA, phytohemaggluti- 
nin. 
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Preparation  of Cell Subpopulations  Selected  by Antiserum  Treatment.  2  x  108  cells  were 
suspended either in  i0.0  or 2.6  ml RPMI;  10  ml or 0.2  ml antisera;  and  10 ml  (1:5)  or 0.2  ml 
undiluted guinea pig complement (C') (Grand Island Biological Company), respectively, then the 
mixture was incubated at 37°C for 45 rain. The residual cells were washed three times, tested for 
viability by trypan blue exclusion, and then suspended in complete medium. AKR anti-C3H anti- 
Thy-l.2  was  obtained  from  Litton  Bionetics,  Inc.,  Kensington,  Md.,  anti-Ig from  Dr.  B.  M. 
Gebhardt (Tumor Biology Unit), goat anti-mouse immunoglobulin from Dr. Rebecca Blackstock 
(Tumor Biology Unit), and the goat anti-IgM and anti-IgG antisera from Meloy Laboratories, Inc., 
Springfield, Va. 
Separation by Plastic Adherence.  Spleen cells suspended in RPMI without serum were incu- 
bated for 2 h  in 5%  CO2 at 37°C  on  100  x  15-mm Falcon plastic Petri dishes (Falcon Plastics, 
Oxnard,  Calif.).  Nonadherent cells were gently poured off,  the plate washed three times with 
RPMI, and the residual adherent cells removed with a  rubber policeman. 
Separation by Nylon Wool Adherence.  Spleen cells were separated on nylon wool columns by a 
modification of the technique of Julius et al (21).  1.5-2.5 × l0  s cells were first passed through glass 
wool at room temperature,  then resuspended in 2 ml of media (RPMI containing 10% fetal calf 
serum [Gibco]), and added to a washed prewarmed nylon wool column. An additional 1 ml of media 
was used to wash the cells into the column. The filled column was resealed loosely and incubated 
for 45-60 rain at 37°C in 5% CO2. Cells not adherent to nylon were harvested by dropwise elution 
with 20 ml warm medium. Another 15 ml media was passed through the column, and the loosely 
adherent cells ("retarded") were removed by a  modified form of the Handwerger and Schwartz 
technique (22). 20 ml warm media was added to the column, and then the nylon wool was squeezed 
with the syringe plunger. This was repeated three times with 5-ml vol of medium, and then twice 
again, after turning the nylon wool over. The samples of each fraction were pooled, washed, and 
the cells resuspended in complete medium. 
Microplate Culture System.  The method employed has been described in detail elsewhere (23). 
5  x  10  s thymus cells were cultured in tissue culture microplates (Falcon Plastics) or Microtest II 
plates (Linbro Chemical Co., Inc., New Haven, Conn.) in combination with varying numbers of 
peripheral lymphoid cells taken from lymph node or spleen in a  vol of 0.2 ml. The mitogens were 
solubilized in RPMI and added in 10-~1 vol. Salmonella typhimurium type-7 endotoxin (LPS) was 
obtained from Dr. J. R. Shands, Department of Immunology and Medical Microbiology, Univer- 
sity of Florida College of Medicine; Salmonella  minnesota R-595 from Dr. W. H. Adler, Gerontol- 
ogy Research Centre,  Baltimore City Hospital,  Baltimore,  Md.; phytohemagglutinin (PHA-P), 
Con  A,  and S.  typhimurium  LPS  were  obtained from Difco  Laboratories,  Detroit,  Mich.  The 
cultures were incubated for 72 or 48 h where indicated at 37°C in 5% CO2. [3H]thymidine ([3H]TdR) 
incorporation was assayed as described previously (23).  Culture results are expressed in terms of 
mean cpm/culture -  SE for quadruplicate cultures. 
Medium-RPMl.  1640  medium,  to which 100  U  of penicillin,  100  gg streptomycin/ml,  and 
Fungizone (Gibco) were added plus 5% heated (56°C for 30 rain) human serum, was used for final 
cultures in all experiments. Mitomycin C (Nutritional Biochemicals, Cleveland, Ohio) was used to 
block thymidine incorporation in some experiments at a concentration of 50 ttg/0.1 ml per 15 ×  10  e 
cells/0.5 ml, incubated at 37°C for 30 rain. The cells were washed three times with RPMI-1640 and 
resuspended in culture medium. Irradiation: 1,000 R was delivered to cell suspensions by a  ~37Cs 
source. 
Determination ofT6 Chromosome Marker.  Cultures prepared as described above were treated 
with colcemid (Gibco) 0.4 ~g/ml 4 h before harvest, then washed in Hanks' balanced salt solution 
(BSS) (Gibco), and resuspended for 15 min in hypotonic BSS (24). Cells were then centrifuged and 
resuspended in a  cold methanol:acetic acid mixture (1:3)  for 15 min. The fixed preparation was 
again centrifuged and resuspended in two drops of the fixative, placed on a clean microscope slide, 
and flamed briefly burning off the methanol. The slides were stained with Giemsa stain,  and 
metaphases were identified and counted. Only those mitotic figures allowing full visualization of 
all chromosomes were evaluated. Approximately one-half of the metaphases in such preparations 
were unsatisfactory for evaluation. 
Results 
LPS-Induced Proliferation  of Thymus  Cells  in  the Presence of Peripheral 
Lymphoid Cells.  The basic observation explored in the series of  experiments to MICHAEL  A.  NORCROSS  AND  RICHARD  T.  SMITH  1301 
TABLE  I 
Comparison of Proliferation Induced in C57BL/10 Thymus, Peripheral, or Thymus- 
Peripheral Cell Mixtures by LPS* 
Experiment  Cells in culture  Thymus/peripheral 
number  cell ratio 
[3H]TdR incorporation (mean cpm 
_+ SE culture) 
Unstimulated  LPS added  culture 
Thymus  81 -+ 10  301  -+  51 
Spleen  211 -+ 105  371  -  188 
Thymus + spleen  1:0.04  214 -  77  2,738  -  203 
Thymus  126 -+ 21  565  -+  17 
Spleen  142 -  25  5,966  -  31 
Thymus + spleen  1:0.04  273 -+ 56  21,417  -  2,381 
Thymus  124 -+ 57  127  -+  7 
Spleen  92 -+ 23  956  -  48 
Thymus + spleen  1:0.04  205 -+ 32  4,011  _+  280 
Thymus  145 -+ 26  208  -  30 
Spleen  285 _+ 32  591  +-  111 
Thymus + spleen  1:0.04  362 -+ 47  4,964  _  230 
Thymus  140 _+ 8  393  -+  18 
LN cells  92 _+ 11  209  _+  44 
Thymus + LN cells  1:0.1  172 _+ 9  3,960  -+  742 
* 5 × 105 C57BL/10  thymus cells and 2 × 104 spleen or 1 × 105 LN cells were incubated separately or 
together and with or without 4 ~g LPS per culture for 72 h. [3H]TdR  was added during the last 
24 h of culture.  Data represent  mean cpm _+ SE of four replicate cultures. 
be described is that cultures of mouse thymus cells, which proliferate minimally 
or not at all in response to LPS (4),  appear to do so strongly when numbers of 
peripheral lymphoid cells too low to respond detectably are added. Table I shows 
four experiments typical of the range of proliferative responses observed when 
thymus cells and spleen cells were combined in a  25:1 ratio in the presence of 
LPS. The cultures containing thymus lymphocytes alone proliferate minimally; 
when splenic lymphocytes are added in numbers that respond minimally to LPS 
alone, a  highly significant amplification of proliferation appears. 
This apparent synergistic effect is dependent upon the ratio between the cells 
of the mixture and the amount of LPS added.  Dose-response kinetics,  explored 
through experiments such as that illustrated in Fig.  1, resemble those of B-cell 
mitogens rather than T-cell mitogens (25).  That  is,  a  linear relationship  was 
found  between  dose  and  degree  of [3H]TdR incorporation  at  low  LPS  levels 
reaching a  plateau at high ranges, without a  significant inhibitory effect upon 
further addition of LPS. 
When lymph node  (LN) cells were used as a  peripheral  cell source,  similar 
amplified proliferation occurred in LPS-stimulated cultures (Table I). The dose- 
response kinetics (Fig.  1) were similar to those seen using spleen cells.  On the 
other hand,  synergistic effects of LN cells at various ratios had kinetics some- 
what  different  from  that  of  spleen  cells  (Figs.  2,  3).  At  high  peripheral 
cell:thymus ratios,  proliferation of spleen, but not LN cells alone, masked any 1302  REGULATION  OF  LPS  B-CELL  RESPONSE 
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FIG.  1.  Effect of co-cultivating 5  ×  105 C57BL/10  thymus cells with 2  ×  104 spleen (ratio 
1:0.04) (left) or 5 ×  104 LN cells (ratio 1:0.1).  (right) on LPS-induced proliferating response. 
The data represent mean cpm/culture +  SE of four replicate cultures. Thymus +  spleen or 
LN (©); spleen or LN alone (©); thymus alone ([]). 
synergism that may have occurred.  Table II summarizes this group of experi- 
ments in terms of an amplification  index.  The synergy occurring with spleen 
cells was greatest at ratios between 1:0.1 and 1:0.04. 
When  the  thymus  cell  concentrations  were  varied,  but the  peripheral  cell 
concentration was kept constant (Fig. 4), proliferation in the resultant mixture 
was  approximately  proportional  to  the  number  of thymus  cells  added.  This 
suggests  that  a  cell  component  of the  thymus  population  was  the  limiting 
element in the combined responses.  When peripheral  cell concentrations were 
varied and thymus remained constant under the same culture conditions (Table 
II),  different  kinetics  emerged;  high  cell  concentrations  usually  inhibited  or 
reduced thymus/peripheral  cell synergy. 
Synergy Requires  that Both Thymus and Peripheral Cells Proliferate.  To 
determine  the  contribution  of each  cell  type to the  augmented  reaction,  the 
thymus or the spleen cell component was either treated with mitomycin C (26) or 
irradiated  (25) before culture  (Table III).  When proliferation  was inhibited  in 
either cell component the synergistic two-cell response to LPS was essentially 
eliminated.  The spleen cell contribution appeared more sensitive to block than 
that  of the thymus;  when  blocked spleen cells  were combined with thymus, 
proliferation  was  reduced  to  the  level  of thymus  cells  alone.  When  blocked 
thymus  cells were combined  with  spleen  cells,  the  combination  retained  the 
response expected of that number of spleen cells alone. It was concluded that the 
synergistic effect observed involves proliferation of both cellular elements. 
Subpopulation  Characteristics of Cells in the Proliferating  Thymus Compo- 
nent.  Immunocompetent thymus cells constitute a minor subpopulation identi- 
fied by responsiveness to T mitogens and alloantigens, graft-versus-host reactiv- 
ity, low net density,  low Thy-1,  and high  H-2 antigen  distribution.  The major 
subpopulation has high net density and high membrane Thy-1 antigen, but has 
none of those attributes that indicate immunocompetence (26, 27). To determine MICHAEL  A.  NORCROSS  AND  RICHARD  T.  SMITH  1303 
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FIG.  2.  Effect of varying LN cell concentration on synergy. 5 x  105 C57BL/10  thymus cells 
were cultured alone or with LN cells in various cell concentrations. Ratios indicate added 
LN cell numbers as follows: 1:1 (5 x  105), 1:0.2 (1 ×  105), 1:0.1 (5 x  104), 1:0.04 (2 × 104). Data 
represent [3H]TdR  incorporation over the last 24  h  of a  72-h culture period expressed as 
mean cpm +- SE for four replicate cultures. Thymus (©); LN alone (e); thymus alone (O). 
which thymus subpopulation was involved in synergistic proliferation, the cells 
were selected either on the basis of density on BSA gradients or selection with 
anti-Thy-l.2 antisera and complement. Table IV illustrates the findings. Selec- 
tive  elimination  of cells  highly sensitive  to  anti-Thy-l.2  and  C'  yielded a 
subpopulation in which Con A responsiveness was apparently concentrated, but 
in which the capacity to support synergistic proliferation remained equivalent to 
whole  unfractionated thymus.  This  suggested that  the  functions  involving 
synergy are independent of Con A responsiveness. 
Cells active in promoting synergy were found at all density levels in BSA 
gradients (Fig.  5),  although any direct LPS activity observed in thymus cells 
alone was limited to cells of lowest net density (26, 27). Low density thymus 
fractions cultured with peripheral cells and LPS gave synergy not significantly 
greater than that given by high density fractions. Selective elimination of high 
Thy-l.2 cells from the high-density fractions with dilute anti-Thy-l.2 plus C' 
yielded a residual subpopulation of 20-30% of cells which supported synergy as 
well as the untreated fraction. Higher concentrations of anti-Thy-l.2 eliminated 
all cells in this fraction. 
The thymus cell  subpopulation  participating in  the  synergistic effect can 
therefore be characterized as one having relatively low Thy-l.2 representation, 
variable net density, and of a different subclass from those cells that respond 
strongly to Con A. 
Characteristics  of  the  Proliferating  Peripheral  Lymphoid  Cell Popula- 
tion.  The  peripheral  cell  involved in  the  synergy effect was  examined for 
properties of adherence to glass or nylon and for sensitivity to anti-Ig, anti-IgG, 1304  REGULATION  OF  LPS  B-CELL  RESPONSE 
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Fro.  3.  Effect  of varying spleen cell  concentration on thymus/spleen mixture  LPS  re- 
sponses. 5 x  105 C57BL/10 thymus cell were co-cultured with spleen cells in levels as follows: 
5 x  105, 1 ×  105, 5 ×  104, and 2 x  104 corresponding to the ratios 1:1, 1:0.2, 1:0.1, and 1:0.04, 
respectively. Data represent mean cpm +_ SE for four replicate cultures. Spleen alone (e); 
thymus  +  spleen (©); thymus alone (D). 
TABLE  II 
Calculated Synergy of LPS-Induced Proliferation in Cultures of Mixtures of 
Thymus and Peripheral Lymphoid Cells Effects  of Va~. ing Cell Ratios* 
Experiment num- 
ber and cells used 
Amplification ratio, by cell ratio used (thymus:peripheral 
lymphocyte) 
1:1  1:0.5  1:0.2  1:0.1  1:0.05  1:0.04 
1.  Spleen  0.79  2.6  4.0  4.6 
2.  Spleen  1.0  2.0  3.0  4.0 
3.  Spleen  1.1  1.1  1.9  4.7 
4.  LN  4.0  4.7  9.7  8.8 
5.  LN  1.6  6.5  5.5  4.0 
* 5 ×  105 thymus cells were cultured with varying numbers of spleen or LN cells and 
either 5 ~g (exp. 1, 2) or 1 ~g (exp. 3-5) LPS. Synergy ratios were calculated: A. R = 
(cpm thymus-peripheral cell mixture)/(cpm thymus alone)  +  (cpm peripheral cell 
alone). 
anti-IgM,  or  anti-Thy-l.2 plus  C'.  Table  V  shows  that  both  adherent and 
nonadherent spleen cells had essentially equal activity in combination with 
thymus cells, while the nonadherent subpopulation had slightly lower levels of 
response to LPS alone. Nylon-column separation (Table VI) concentrated the 
proliferating peripheral cell in the retarded fraction. The cell population re- 
tarded by nylon had been previously filtered through glass wool, thus essen- 
tially eliminating a role of macrophages that are reported to potentiate T-cell 
functions in other contexts (28-31). The retarded subpopulation appeared di- 
rectly responsive to LPS to a degree equal to that of the unseparated cells and 
contained cells giving synergistic activity when combined with thymus cells. 
Selection of cell populations by treatment with anti-Ig, anti-IgG, or anti-IgM 
plus C' reduced LPS-induced proliferation and eliminated most B-cell functions MICHAEL  A.  NORCROSS  AND  RICHARD  T.  SMITH 
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Fro.  4.  Effect of varying thymus cell concentration on synergy. 5 x  104 spleen cells were 
cultured  with  5  ~tg  LPS  alone  and  with thymus cells in  the  indicated concentrations. 
[3H]TdR  incorporation was  measured  over  the  last  24  h  of a  72-h  culture  period  and 
represented as mean cpm -+ SE for quadruplicate. Thymus +  LPS (e); thymus +  spleen + 
LPS (©). 
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(32). As is illustrated in Table VII, tllis treatment both reduced drastically the 
LPS response level of spleen cells and essentially eliminated synergistic prolifer- 
ation with thymus cells. Anti-Thy-l.2 and complement used in similar experi- 
ments either had no effect or in some cases enhanced synergistic proliferation 
(Table VIII). 
Comparison of the Contribution  of  LPS Responder or Nonresponder  Status to 
the  Synergy Effect.  Spleen  cells from C3H/HeJ  mice are low responders to 
LPS,  in  contrast to  most  C3H  strains  (33-35).  Combinations  of thymus and 
spleen from the low-responder strain (C3H/HeJ) with cells from a closely related 
and non-MLR reactive high-responder strain (C3Heb/FeJ) were tested to deter- 
mine how responder status contributed to synergistic proliferation in the sys- 
tem. It is evident from Table IX that the synergy effect occurs only when the 
peripheral component is of responder origin. The thymus cell component did not 
require responder status. These results are interpreted to mean that the periph- 
eral cell must be LPS responsive to be synergistic with T cells. 
Karyotypic Analysis Using Mixtures  of T6 and Non-T6 Thymus and Spleen 
Cells.  The relative contribution of each cell component to synergistic prolifera- 
tion  was  resolved using CBA/H-T6J  (T6)  and  CBA/Caj  (Ca)  histocompatible 
thymus and spleen combinations (Table X).  Either T6 thymus or spleen cells 
were cultured together with  Ca thymus or spleen cells,  and  after 72  h,  the 
presence of the T6  markers was determined in each satisfactory metaphase. 
Replicative cultures were assayed for [3H]TdR incorporation. 
The thymus cell contribution, although detectable in every culture, proved to 
be minimal.  Only 2-10%  of the tota]  dividing cells in cultures showing aug- 
mented proliferation  in  response  to  LPS  were of thymus  origin.  90-98%  of 
proliferating cells in the synergistic cultures were of peripheral cell origin. 
Discussion 
The data presented demonstrate that synergistic proliferation occurs when a 
low Thy-1, non-Con A responsive thymus T-cell subpopulation is cultured with 
small numbers of peripheral B cells in the presence of LPS.  Synergy requires 1306  REGULATION  OF  LPS  B-CELL  RESPONSE 
TABLE  III 
Effect of Mitomycin Treatment or Irradiation of Thymus or Peripheral Cell Component 
on Synergy of LPS Response* 
Cells in culture and treatment 
Thymus: spleen 
ratio 
[3H]TdR incorporation (mean cpm +_ 
SE/culture) 
Unstimulated  LPS 
1.  Thymus alone  (5  ×  105) 
Thymus [M] alone (5  ×  105) 
Spleen  [M]  (4  ×  105) 
Spleen (4  ×  105) 
Spleen alone (2  x  104) 
Spleen  [M]  (2  ×  104) 
Thymus +  spleen (2  ×  104) 
Thymus [M] +  spleen (2 ×  104) 
Thymus +  spleen [M] (2 x  104) 
1:0.04 
1:0.04 
1:0.04 
345  --  111  684  -+  92 
190  _+  31  271  _+  26 
175  -+  16  184  -+  25 
3,285  +_  270  20,968  +-  830 
409  -  155  257  -+  173 
141  _+  23  383  _+  48 
493  +_  155  5,895  -+  157 
156  _+  29  254  __  48 
271  _+  52  665  -+  119 
2.  Thymus alone (5  ×  105) 
Spleen  (4  x  105) 
Spleen  [M]  (4  ×  105) 
Spleen alone (2  ×  104) 
Thymus +  spleen (2  ×  104) 
Thymus +  spleen [M] (2 ×  104) 
1:0.04 
1:0.04 
100  -+  17  160  -+  20 
4,559  _+  439  14,460  _+  1,045 
55  +-  6  67  _+  4 
69  _+  6  219  _+  94 
125  -+  22  5,314  -+  482 
125  _+  23  235  +_  11 
3. Thymus alone (5 × 105) 
Thymus  [X] alone (5 x 105) 
Spleen alone (5 × 105) 
Spleen [X] alone (5 × 105) 
Thymus  + spleen (5 × 105)  1:1 
Thymus [X] + spleen (5 x 105)  1:1 
Thymus + spleen [X] (5 × 105)  1:1 
Spleen (1 × 105) 
Spleen [X] (1 × 105) 
Thymus  + spleen (1 x 105)  1:0.2 
Thymus [X] + spleen (1 × 105)  1:0.2 
Thymus + spleen [X] (1 × 105)  1:0.2 
Spleen (5 × 104) 
Spleen [X] (5 x 104) 
Thymus  + spleen (5 × 104)  1:0.1 
Thymus [X] + spleen (5 × 104)  1:0.1 
Thymus + spleen [X] (5 x 104)  1:0.1 
Spleen (2 × 104) 
Spleen [X] (2 × 104) 
Thymus  + spleen (2 × 104)  1:0.04 
Thymus [X] + spleen (2 x 104)  1:0.04 
Thymus  + spleen [X] (2 × 104)  1:0.04 
320  _+  150  257  -  21 
46  _+  4  69  -+  17 
16,804  -4-  1,495  54,796  _+  685 
844  _+  96  1,076  +_  86 
15,115  _  717  56,796  +-  5,747 
15,444  _+  1,015  59,218  -+  4,894 
905  -+  127  1,560  -+  33 
1,646  +-  89  15,704  +-  592 
133  +-  8  251  -+  37 
3,394  +-  221  32,921  +-  685 
2,756  +-  118  17,427  _+  584 
546  _+  22 
618  +_  49  6,091  -+  94 
152  -+  80  83  -+  8 
1,196  -  98  19,051  -  245 
1,295  -+  132  5,987  -+  353 
145  _  14  419  _+  49 
183  _+  24  1,057  --+- 23 
68  +_  11  66  _+  13 
398  +-  59  5,234  -  288 
303  -+  28  860  +-  117 
103  _+  10  231  _  14 
* C57BL/10 thymus and spleen were mitomycin [M]-treated or irradiated  IX] with 1,000 R  then 
used in combinations above adding 4  ~g LPS to stimulate cultures.  [3H]TdR was added during 
the last 24 h  and the data presented as the mean values for quadruplicate cultures  -+  SE. 
proliferation  of  both  the  thymus  and  peripheral  lymphoid  cell  component. 
However,  the  major  proliferative  activity  is  due  to  greatly  augmented  cell 
division  of the  peripheral  B-cell  elements;  the  T-cell  contribution  is apparently 
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TABLE IV 
Effect of Anti-Thy-1.2 Plus Complement Treatment of Thymus Cells on Proliferative 
Response to LPS of Thymus~Spleen  Cell Mixtures* 
Thymus: spleen 
Experimental  groups  ratio 
[3H]TdR incorporation  (mean  cpm -* SE/culture) 
Uustimulated  LPS  Con A 
1.  Whole thymus  (C')  (5  x  10  s)  57  ±  2  78  +_  7 
Anti-Thy-l.2  +  C'-treated  thymus  (5  x  83  ±  9  120  ±  5 
10  s) 
Spleen (5  x  104) alone  149  ~  24  2,407  +-  126 
Thymus  (C')  +  spleen (5  ×  104)  1:0.1  318  ~  8  16,129  ±  774 
Anti-Thy-l.2 plus C'-treated  thymus  +  1:0.1  355  ±  20  14,179  ±  379 
spleen (2  ×  104) 
2. Low density thymus (C')  (5 x los) 
Low density thymus (anti-Thy-I.  2 plus 
C' treated)  (5 × los) 
2,715  ±  143 
15,005  ±  1,223 
3,530  ±  104 
42  ±  2  29  ±  1  479  ±  103 
64  ±  1  48  ±  2  2,564  ±  69 
Spleen (5  ×  104)  75  ±  24 
Low density thymus (C') (5 x  los) +  I:0.I  85 ± 4 
spleen (5 x 104) 
Low density thymus (anti-Thy-l.2  plus  i:0.I  88 ±  3 
C'  treated)  (5 × 105)  + spleen (5 x 104) 
314  ±  36 
1,916  ±  39 
3,214  ±  134 
1,224  ±  88 
58  ±  2  67  ±  7  309  ±  52 
78  ±  8  102  ±  4  2,343  ±  349 
61  ±  6  3,069  -+  109 
193  ±  30  13,510  ±  1,012  1:0.1 
1:0.1 
3. High density thymus (C')  (5 x los) 
High density  thymus (anti-Thy-l.2  plus 
C')  (5  x  l0  s) 
Spleen (5  x  10  ~) 
High density  thymus  (C')  (5  x  los)  + 
spleen (5  ×  104) 
'High density thymus  (anti-Thy-l.2 plus 
C')  (5  x  10s}  +  spleen (5  x  10  4) 
206  ±  28  13,787  +-  286 
* Nylon column passed C57BL/10 whole thymus cells (exp. 1), low density (fraction "A + B") (exp. 
2), or high density (fraction "D") (exp. 3) thymus cells were treated with anti-Thy-l.2 antiserum, 
1:100 plus 1:15 guinea pig complement or complement alone at 37°C for 45 min and washed. 5 × 
105 cells of the control or anti-Thy-l.2-resistant  subpopulations  were cultured with spleen cells 
and 1 ftg LPS or 1/~g Con A as indicated. [SH]TdR incorporation was assayed during the last 24 h 
of a  48-h  culture.  Mean  cpm  _+  SE  are  for  four  replicate  cultures.  1:100 anti-Thy-l.2  plus 
complement  killed 70-75% of high density cells, 30-35%  of low density cells, and 50% of whole 
thymus cells. 1:50 anti-Thy-l.2 killed 96% of high density thymus cells and 75% of whole thymus. 
The thymus cell component which supplies this amplifier effect has character- 
istics  that  do  not  identify  it  clearly  with  those  thymus  cell  subpopulations 
previously described (20, 25, 27, 36). Moreover, it appears not to require macro- 
phages to function. The responsible cell was distributed equally in high- and low- 
density thymus cells. The latter contain those immunocompetent T-cell subpop- 
ulations that are both T-mitogen and alloantigen responsive, and have T-helper 
cell functions; the former does not exhibit these functions. The amplifier cells 
are in the high-density fraction which is killed by higher concentrations of anti- 
Thy-l.2 and C'. Those anti-Thy-l.2 concentrations which appear to concentrate 
immunocompetent cell functions, retain amplifier function but not at a  level 
greater than the whole thymus or untreated high density cells. The amplifier 
cell is therefore characterized as a thymus T cell of varying density, having Thy- 
1.2 representation, but apparently not an immunocompetent T cell. 
The peripheral cell has properties that identify it as a B lymphocyte, includ- 
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FrG.  5.  Effect of separation of thymus cells on discontinuous BSA density gradients on 
LPS synergy with spleen cells. 5 x  105 C57BL/10 thymus cells obtained from BSA gradients 
were incubated with 5  ×  104 spleen cells for 72 h  after adding indicated mitogens.  [3H]TdR 
incorporation  was  assayed  during  the  last  24  h;  the  data  represent mean  cpm  of four 
cultures  _+  SE.  Alloantigen  responses  were  to  0.25  x  106  irradiated  CBA  spleen  cells 
(responder  to  target  ratio  2:1).  Unstimulated  ([~);  LPS  alone  ([]);  spleen  +  LPS  (ll); 
alloantigen ([]). 
TABLE  V 
Adherence Properties of Spleen  Cells in Synergistic Thymus~Spleen  LPS 
Response* 
Cells 
[3H]TdR incorporation (mean cpm + 
SE culture) 
Unstimulated  LPS (4 /~g) 
Thymus (5  x  105  )  359  -+  63  936  _+  79 
Spleen (whole) (4  x  105)  2,343  _  288  24,933  _+  997 
Spleen nonadherent (4  x  105)  1,664  _  79  18,634  -+  1,403 
Spleen adherent (4  x  105)  1,499  -+  69  25,843  _+  1,304 
Spleen (whole) (2  x  104  )  295  -+  45  406  -+  43 
Spleen nonadherent (2  ×  104)  277  +  48  199  -  34 
Spleen adherent (2  x  104  )  127  _+  11  183  +_  11 
Thymus  +  (whole) spleen (2  ×  104)  493  -+  155  5,896  _+  157 
Thymus  +  nonadherent spleen (2  x  104)  194  +_  52  4,783  +  367 
Thymus  +  adherent spleen ( 2  ×  104)  277  -+  43  6,279  _+  254 
* C57BL/10 spleen cells were plated in Petri dishes and incubated for 2 h  at 37°C in 
5% CO~. Nonadherent cells were poured off, the plate washed three times, and then 
the  nonadherent cells removed  with  a  rubber policeman.  These subpopulations 
were cultured 72 h as indicated assaying for [3H]TdR incorporation during the last 
24 h.  Data represent mean value _  SE for four replicate cultures. 
by  anti-Ig,  anti-IgG,  or  anti-IgM  antiserum  plus  C'.  Optimal  synergy  is  seen 
when  the  peripheral  cells are  used  in relatively  low numbers,  which  alone  react 
minimally  to LPS.  Numbers  of peripheral  cells which  showed  good responses  to 
LPS  alone  did not demonstrate  detectable  synergy  when  combined  with  thymus 
cells under  these  conditions. MICHAEL  A.  NORCROSS  AND  RICHARD  T.  SMITH  1309 
TABLE  VI 
Effect of Nylon Column Passage of Spleen Cells Upon LPS Synergy in Thymus~Spleen 
Cell Mixtures* 
Cells  Thymus: spleen 
ratio 
[3H]TdR incorporation  (mean cpm  .+ SE/culture) 
Unstimulated  LPS  PHA 
Thymus alone (5 x  10  ~)  109  .+  11  239  .+  27 
Spleen alone (5 x  1O  s)  8,623  .+  755  83,953  -+  2,720 
Passed spleen alone (5 x  105)  3,875  .+  286  18,683  .+  473 
Retarded spleen alone (5 ×  10  s)  7,219  .+  427  84,836  ±  1,251 
Spleen alone (5 ×  10  ~)  276  _+  9  2,607  .+  176 
Passed spleen aone (5 x  10  ~)  257  _+  36  333  .+  32 
Retarded spleen alone (5 ×  104)  213  .+  20  3,150  _+  75 
Thymus +  spleen (5 x  104)  1:0.1  610  .+  43  14,033  .+  288 
Thymus  +  passed spleen (5 x  104)  I:0.I  490  .+ 96  1,971  ±  103 
Thymus  + retarded spleen (5 x  104)  1:0.1  577  .+ 71  25,482  ±  1,011 
Spleen alone (2 ×  104)  171  ±  10  517  .+ 40 
Passed spleen alone (2 ×  104)  140  ±  10  241  .+ 10 
Retarded spleen alone (2 x  I04)  136  ±  20  646  .+ 61 
Thymus  + spleen (2 x  104)  1:0.04  270  .+ 0  4,875  .+ 407 
Thymus +  nonadherent spleen (2 x  104)  1:0.04  485  ±  188  856  .+  154 
Thymus +  adherent spleen (2 x  104)  1:0.04  349  ±  24  6,245  .+  1,495 
296  .+  9 
62,383  .+  3,168 
92,906  .+  3,878 
63,580  .+  2,350 
* C57BL/10 spleen cells were first filtered through glass wool and then incubated for 60 rain at 37°C in a nylon wool column. The 
column was eluted, the passed cells collected, washed, and used as above. The cells remaining ("retarded") were removed by 
compressing the nylon collecting the loosely adherent cells. These cells were cultured as indicated with 5  x  10  ~ thymus cells. 
Counts represent [SH]TdR incorporation for four replicate cultures ±  SE. 
TABLE VII 
Effect of  Anti-Immunoglobulin Plus Complement on Capacity of Spleen Cells to Support 
LPS Synergy when Cultured with Thymus Cells* 
Experiment and procedures  Thymus: spleen 
ratio 
[3H]TdR incorporation  (mean cpm -+ SE/culture) 
Unstimulated  LPS  Con A 
I. Thymus  alone (5 x  I0  s) 
Spleen alone (4 x  i0  ~) 
Anti-Ig plus C'-treated  spleen alone (4 
x  I0  s) 
Spleen alone (4 x  104) 
Anti-Ig plus C'-treated spleen alone (4 
x  104) 
Thymus  + spleen (4 x  104) 
Thymus  +  anti-lg  plus  C'-treated 
spleen (4 x  104) 
2. Thymus  alone (5 x  105) 
Complement-treated  spleen alone (4 × 
IO  s  ) 
Complement-treated spleen alone (2  × 
10  4  ) 
Anti-IgG plus C'-treated spleen alone (4 
×  105) 
Anti-IgG plus C'-treated spleen alone (2 
x  104) 
Anti-lgM  plus C'-treated  spleen alone 
(4 x  l0  s) 
Anti-lgM  plus C'-treated  spleen alone 
(2  x  i0  ') 
Thymus + C'-treated  spleen (2 × i04) 
Thymus  +  Anti-lgG plus  C'-treated 
spleen (2 x  104) 
Thymus  +  Anti-lgM  plus  C'-treated 
spleen (2  x  i04) 
284  .+  95  347  .+  39 
1,533  ±  355  25,639  .+  1,503 
348  .+  65  2,130  ±  194 
292  .+  55  822  .+  30 
293  .+  105  553  .+  47 
1:0.08  198  .+  53  6,294  .+  604 
1:0.08  249  .+  72  1,195  .+  134 
91  ±  11  301  .+  41 
7,004  .+  947  48,334  .+  1,215 
597  .+  187  523  .+  192 
803  .+  66  11,038  .+  1,327 
36  .+  3  166  .+  56 
2,048  .+  322  21,140  ±  1,085 
138  ±  62  243  .+  121 
1:0.04  270  .+  153  3,154  ±  254 
1:0.04  201  .+  73  670  .+  108 
1:0.04  204  .+  62  608  .+  57 
65,711  .+ 3,550 
80,819  .+ 1,286 
70,572  .+ 4,378 
* C57BL/10 spleen cells were treated with 1:15 dilutions anti-Ig, anti.IgG, or anti-IgM, plus 1:15 guinea pig complement, incubated 
at 37°C for 45 rain, and then washed. The residual subpopulation was cultured alone or in combination with thymus cells, with or 
without 4 ~g LPS or 0.5 ~g Con  A.  [3H]TdR  incorporation assayed in four replicate cultures. 1310  REGULATION  OF  LPS  B-CELL  RESPONSE 
TABLE VIII 
Effect of Anti-Thy-l.2 and Complement Treatment of Spleen on Thymus-Spleen LPS 
Synergy* 
Experiment  and procedure  Thymus: spleen 
ratio 
[3H]TdR incorporation  (mean cpm ± SE/culture} 
Unstimulated  LPS  PHA 
1. Thymus (5 x  10  ~)  46  ±  7  326  ±  24 
Complement.treated  spleen (5 × 10  ~)  1,092  ±  122  63,339  ±  1,755 
Anti-Thy-l.2  plus  C'-treated spleen  (5  520  ±  60  47,187  ±  1,177 
x  10  b) 
Complement4reated spleen (2 x  i04)  41 ±  13  1,274 ±  110 
Anti-Thy-l.2 plus C'-treated  spleen (2  45 ±  12  1,352 ±  202 
x  104) 
Thymus + C'-treated spleen (2 × 10  ~)  1:0.04  188  -+  50  6,013  ±  286 
Thymus + Anti-Thy-l.2  plus C'-treated  1:0.04  122  ±  17  5,311  ±  205 
spleen (2 × 104) 
2. Thymus (5 × i0  ~)  174 ±  19  280 ±  15 
Complement-treated spleen (5 × I{P)  883 ±  58  53,700 ±  720 
Anti-Thy-l.2 plus C'-treated spleen (5  2,148 ±  98  73,697 ±  526 
×  105) 
Complement-treated spleen (5 x I04)  77 ±  4  2,778 ±  i16 
Anti-Thy-l.2 plus C'-treated spleen (5  101 ±  7  7,751 ±  391 
x  104) 
Thymus + C'-treated spleen (5 x 104)  1:0.1  248  ±  33  10,034  ±  376 
Thymus + Anti-Thy-l.2 plus C'-treated  1:0.1  314  ±  62  19,135  ±  499 
spleen (5 × 104) 
32,335 ± 741 
1,880 ± 157 
28,858 ± 1,156 
3,073 -+  190 
* C57BL/10 spleen cells were treated with 1:45 dilution of anti-Thy-l.2,  plus 1:15 guinea pig complement, incubated at 37°C for 45 
rain, and washed. The residual  populations were cultured  alone or in combination with thymus cells together with 5/~g LPS or 
0.05 ~l  PHA added  as indicated.  Data represent mean cpm  ±  SE  for four  cultures  incubated  for 72  h  assaying [3H]TdR 
incorporation during the last 24 h. 
TABLE IX 
Contribution of LPS-Responder Strain (C3HeB/FeJ) or Nonresponder (C3H/HeJ) 
Spleen or Thymus Cells to LPS Synergy* 
Origin of cells cultured 
Thymus: 
spleen ratio 
[3H]TdR  incorporation  (mean  _+ 
SE/culture) 
Unstimulated  LPS added 
C3H/HeJ  thymus  alone 
C3HeB/FeJ  thymus  alone 
C3H/HeJ  spleen alone 
C3Heb/FeJ  spleen alone 
C3H/HeJ  thymus  +  C3H/HeJ  spleen 
C3HeB/FeJ  thymus  +  C3HeB/FeJ  spleen 
C3H/HeJ  thymus  +  C3HeB/FeJ  spleen 
C3HeB/FeJ  thymus  +  C3H/HeJ  spleen 
1:0.04 
1:0.04 
1:0.04 
1:0.04 
328  -+  42  121  _+  13 
353  -+  18  125  _+  5 
125  -+  16  120  +_  18 
135  +-  16  1,064  _+  100 
360  -  33  538  -+  33 
478  -+  48  4,746  _+  433 
610  -  102  5,807  _+  596 
459  -+  23  542  _+  46 
* C3HeB/FeJ  or C3H/HeJ  thymus  cells (5 x  105) were  cultured with 2 x  104 spleen cells of  the same 
or other  strain  together  with  or without  1.0  ~g  LPS.  Data  are  mean  values  -+  SE  for four 
replicate cultures. 
The extent of proliferation by each component was assessed by using the T6 
chromosome markers; most cell division was contributed by the B-lymphocyte 
component with only 2-10% of dividing cells in the mixture being of thymus 
origin. The B-cell-like dose-response kinetics of the synergistic effect are consist- 
ent  with  this  finding.  The  minimal  level  of thymus  proliferation  observed 
appears to be essential for amplified B-cell responses. 
The data available permit construction of a working hypothesis involving a MICHAEL  A.  NORCROSS  AND  RICHARD  T.  SMITH  1311 
TABLE X 
Relative Contribution of Thymus and Spleen Cells to LPS Synergy as Defined by T6 
Chromosome  Markers* 
Experiment 
Number  Percent 
[3H]TdR incor- 
T6 meta-  meta- 
Cell source and strain of  LPS (5  poration (mean  phases/  phases of 
origin  ~g)  cpm _+  SE/cul- 
ture)  number of  thymus 
non-T6$  origin 
Thymus (T6)  -  105  -+  21 
+  123  __  23 
Spleen (Ca)  -  95  -+  36 
+  354  -+  65 
Thymus (T6)  +  spleen (Ca)  -  190  _  21 
+  4,012  -+  333  1/66  1.5 
Thymus (Ca)  -  83  -+  8 
+  94_+6 
Spleen (T6)  -  67  _+  3 
+  447  -  28 
Thymus (Ca)  +  spleen (T6)  -  311  _+  55  219/23  9.5 
+  7,261  _+  410 
2  Thymus (T6)  -  57  -+  11  0/0§  0 
+  144  _+  21 
Spleen (Ca)  -  61  _+  11 
+  4,801  _+  360 
Thymus (T6)  +  spleen (Ca)  -  141  __  27 
+  19,596  _+  1,817  8/193  4 
* CBA/CaJ (Ca) or  CBA/H-T6J (T6)  thymus (5 x 10  ~)  or  spleen (5 x 104)  cells  were cultured 48 h 
(exp.  1)  or 72  h (exp.  2); [3H]TdR was added during  the last  24  h. To replicate  cultures,  4 pg/ml 
Colcemid was added during the last  4 h of  culture;  metaphase plates  were examined for the 
presence or  absence of  the T6 chromosome markers. 
Numbers given are for  those metaphases technically  satisfactory  for  evaluation.  The relatively 
higher value for  thymus (underlined)  may reflect  difficulty  in identifying  T6 markers even in 
technically  satisfactory  preparations. 
§ No metaphases observed. 
sequence of cellular interactions.  Briefly, the first step is postulated to involve 
direct LPS stimulation of the small subpopulation of peripheral B cells added to 
the  mixture.  As a  result  of this  stimulation  a  subclass of thymus  T  cells  is 
activated.  The activated T cells in some way exert a  stimulatory or regulatory 
effect on the ongoing LPS-induced B-cell proliferation which greatly increases 
the level of [3H]TdR incorporation finally measured. 
The initial step appears to be a direct B-mitogen effect because (a) the thymus 
component  does  not  respond  to  LPS  directly,  and  (b)  the  B-cell-containing 
population is known to respond to LPS without any helper cell requirement (37, 
38). 1312  REGULATION  OF  LPS  B-CELL  RESPONSE 
The next step is postulated to involve activation of the thymus cell component 
because (a) synergy requires these T cells and (b) supernates from LPS-stimu- 
lated peripheral B cells cause proliferation of high-density thymus cells with T- 
cell-like kinetics (M.  A.  Norcross and R.  T.  Smith,  unpublished data).  It is 
unlikely that this factor is macrophage derived, as is apparently true of the 
lymphocyte stimulating factor  (LAF)  described by  others  (28-30). Both  the 
peripheral population involved and the thymus cells can be completely depleted 
of macrophages without interfering with synergy. A very small proportion of B 
cells  (less than 5%  of the cultured cell mixture) is required to  activate the 
thymus cell component. Conceivably, apparent macrophage effects seen in other 
systems could be explained through the contribution of small numbers of B cells 
in the adherent cell fractions employed as a macrophage source. 
In the last proposed step the activated T-cell component augments or regu- 
lates  ongoing B-cell  proliferation stimulated by LPS.  This  regulatory effect 
might occur (a) by recruiting previously unresponsive B cells; (b) by nonspecifi- 
cally facilitating proliferation of cells already dividing; or (c) by releasing B cells 
from suppression. In any case, the B cells in the augmented response could be 
responding to a T-cell product alone, to LPS, or to both. 
If the artificial system we have described is interpreted correctly, perhaps an 
analogous peripheral T-cell component regulates B-cell  responses to  LPS  in 
peripheral lymphoid tissues. Tumor-bearing mice and Bacille Calmette Guerin- 
treated mice show greatly augmented LPS responses in regional lymph nodes, 
far in excess of any increase in T- or B-cell numbers in those nodes (23). This 
could represent an  in  vivo reflection of the  in  vitro phenomenon described. 
However, this does not appear congruent with the observation (5) that periph- 
eral lymphoid cells pretreated with anti-0 and C'  either show comparable or 
enhanced LPS proliferation in the residual population. The known subclasses of 
peripheral T cells are quite sensitive to anti-Thy-1 and C' treatment; a dimin- 
ished response therefore would be expected unless a suppressor T cell were also 
eliminated or a helper cell were concentrated. Pre-T cells are present in spleen 
and bone marrow of the normal mouse, but not in peripheral blood or lymph 
nodes. Both of these cell populations are poor responders to LPS (39). Pre-T cells 
are found in spleens of both nude (40) or thymectomized (41) mice which show 
excellent LPS responses. Pre-T cells, if exposed to thymosin, develop character- 
istic thymus antigens (41, 42). It seems possible that the pre-T cell might provide 
an equivalent of the amplifier thymus cell subpopulation in augmenting LPS- 
induced B-cell  proliferation. Attempts to  identify a  T-regulatory cell among 
peripheral lymphoid cells are in progress. 
Summary 
When thymus cells which are unresponsive to LPS are combined with num- 
bers of peripheral lymphoid cells giving minimal responses to LPS, synergistic 
incorporation of [3H]thymidine occurs. Synergy requires that both components 
proliferate, but most of the augmented response is the result of peripheral cell 
proliferation. The thymus cell is a  T  cell of variable density, low in thy-l.2 
antigen, not concanavalin A responsive, present in the major thymus subpopu- 
lation,  and may be from lipopolysaccharide (LPS)-unresponsive strains.  The MICHAEL  A.  NORCROSS  AND  RICHARD  T.  SMITH  1313 
peripheral cell is sensitive to anti-IgG or IgM plus complement (C'), resistant to 
anti-Thy-l.2 and C', exhibits adherence properties of B lymphocytes, and must 
be from LPS-responsive strains.  Synergistic responses depend on critical thy- 
mus/peripheral cell ratios, inhibition occurring at high peripheral cell numbers. 
The data  provide evidence that  B-cell proliferative responses  to LPS may be 
regulated by a  subclass of thymus T  cells. 
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